Related by context. All words. (Click for frequent words.) 71 Milestone Payments 71 License Option Agreement 70 Initiates Clinical 70 Milestone Payment 67 Exclusive License Agreement 66 Supply Agreements 66 Taiho Pharmaceutical 66 Collaboration Agreement 66 Galderma SA 65 Definitive Merger Agreement 64 NDA Submission 64 Exclusive Licensing Agreement 64 Milestone Payment From 64 Receives Milestone Payment 64 Juvantia 64 Drug Candidate 64 Receive Milestone Payment 64 Meets Primary Endpoint 64 InNexus Biotechnology 63 License Agreement 63 Distribution Agreements 63 Initiates Enrollment 63 Patent License Agreement 63 Biomarker Study 63 Syntonix 63 Completes Patient Enrollment 63 Clinical Trials Agreement 63 Earns Milestone Payment 63 Enters Into Collaboration 63 Fresenius Biotech 63 Sublicense 63 POTELLIGENT R Technology 63 InterfeRx 63 Financing Agreements 63 Flamel Technologies Announces 63 Worldwide Licensing Agreement 63 Transcept Pharmaceuticals 63 Exclusive License 63 Therapeutic Competitors Companies 63 Phase 2a Trial 62 ENZON 62 Loramyc ™ 62 VIVITROL ® 62 Initiates Clinical Trial 62 Phase IIb Trial 62 License Pact 62 Receives Orphan Drug 62 Seikagaku Corporation 62 Psoriasis Drug 62 JAK2 Inhibitor 62 Submits NDA 62 RNAi Therapeutics 62 Nasdaq HALO 62 Misonix Announces 62 ABILIFY ® 62 Japanese Encephalitis Vaccine 62 Phase 2b Clinical Trial 62 Files IND 62 Sublicense Agreement 62 Initiates Phase III 62 R#/MEM 62 Licensing Agreements 62 Commence Phase 62 Initiates Phase II 62 Licensing Agreement 62 RECOTHROM R 62 Therapeutic Antibody 62 Kissei Pharmaceutical 61 Urocidin TM 61 Increlex TM 61 Idera Pharmaceuticals 61 ACAPODENE R 61 ESTRASORB R 61 Anticancer Agent 61 Phase III Trial 61 Committed Equity 61 Subsidiary Enters 61 FOLOTYN ® 61 Presents Preclinical Data 61 Inc Therapeutic Competitors 61 Testosterone Gel 61 Portola Pharmaceuticals 61 Anti Tumor 61 AnGes 61 Civacir 61 Kyowa Kirin 61 Announces Poster Presentations 61 Patent Covering 61 Aurora Kinase 61 Asentar TM 61 BioSante Pharmaceuticals Announces 61 Receives Orphan Drug Designation 61 Personalized Immunotherapy 61 Dynepo TM 61 Argatroban 61 Oncolys 61 AB OMXS BINV 61 Clinical Trial Results 61 RECOTHROM ® 61 Phase III Clinical Trial 61 Ecallantide 61 mertansine 61 Nippon Kayaku 61 Waiver Agreement 61 RAPTIVA R 61 Tanabe Seiyaku 61 Hsp# Inhibitor 61 Enters Into Licensing Agreement 61 Tekturna Rasilez 60 Phase IIa Clinical Trial 60 Nycomed GmbH 60 Initiates Phase 2b 60 Vernalis plc 60 Cross License Agreement 60 HuMax TAC 60 Files Investigational 60 methylnaltrexone bromide 60 Pafuramidine 60 Oracea ® 60 outlicensed 60 rxRNA 60 Receives Fast Track 60 IV APAP 60 prostone 60 InvaGen 60 Patient Enrollment 60 Miraculins Announces 60 Phase III Trials 60 GenWay Biotech 60 Anti CD# Antibody 60 Announce Licensing 60 Omigard TM 60 RNAi Therapeutic 60 Seasonal Influenza Vaccine 60 Monoclonal Antibody 60 ATL# [002] 60 Phase IIb Clinical Trial 60 Alnylam Pharma 60 Novel Oral 60 Initiates Clinical Trials 60 Present Preclinical Data 60 BioGlue R 60 JHP Pharmaceuticals LLC 60 AMEX AKN today 60 Lupus Drug 60 Immunotherapeutic 60 Elan Pharma 60 Distributor Agreement 60 SAFLUTAN 60 Fortical ® 60 Phase 1b Clinical Trial 60 Announces Initiation 60 Therapeutic Competitors Report 60 Receptor Agonist 60 GATTEX TM 60 Kyowa Hakko Kirin 60 SYCREST 60 VaxImmune 60 DOV Pharmaceutical 60 registrational studies 60 Loramyc TM 60 lixivaptan 60 TRANSDUR ™ 60 Cellgate Inc. 60 Obtains License 60 Antibody Discovery 60 Aloxi ® 60 Potelligent Technology 60 Allovectin 7 r 60 HDAC Inhibitor 60 FDA Accepts 60 Licenses Novel 60 Zor Pharmaceuticals 60 Prostate Cancer Vaccine 60 Distributorship Agreement 59 Fast Track Status 59 IV Busulfex 59 cinacalcet HCl 59 NASDAQ ALNY 59 Handok Pharmaceuticals 59 Begins Dosing 59 NASDAQ FLML 59 Tostrex 59 Investigational Treatment 59 Announce License Agreement 59 elbion 59 IND Application 59 Exclusive Licensing 59 BioGeneriX 59 Mutually Agree 59 Securities Purchase Agreements 59 Paladin Labs 59 Ridaforolimus 59 Oncaspar 59 Million Milestone Payment 59 Initiates Dosing 59 Æterna Zentaris 59 Antibody Drug Conjugate 59 Nanobody R 59 CIP TRAMADOL ER 59 Develop Novel 59 Tezampanel 59 TKB# 59 HIV integrase inhibitor 59 Esprit Pharma 59 Teaming Agreement 59 Phase III Clinical Trials 59 NasdaqGM NTEC today 59 Presents Positive Preclinical 59 OMJPI 59 JAK Inhibitor 59 Through Glycoscience ® 59 commercialize Aganocides 59 Gout Drug 59 Cetrorelix 59 Indaflex TM 59 GTC NASDAQ GTCB 59 Marketing Authorisation 59 TRX1 59 Captisol ® 59 5 HT3 antagonist 59 Submits Biologics License Application 59 NASDAQ PGNX 59 ELADUR TM 59 SpeBio joint venture 59 Oral Calcitonin 59 Phase 2a Study 59 IND Filing 59 mGluR2 positive 59 Alnylam Nasdaq ALNY 59 Recombinant Human 59 Phase III Pivotal 59 Receives Approvable Letter 59 Announces Tentative Approval 59 Generic Version 59 Phase 2a Clinical Trial 59 MEK Inhibitor 59 Sensipar R 59 BioDelivery Sciences 59 Initiates Phase 59 Licensing Pact 59 PROTONIX 59 MOVIPREP R 59 CORLUX CORT # 59 XL# anticancer compounds 59 Pandemic Influenza Vaccines 59 Elagolix 59 Kuvan R 59 Presents Positive 59 Distribution Agreement 59 ARCALYST R 59 Successfully Completes Phase 59 Regeneron Pharma 59 Albugon 59 GRAS Status 59 vernakalant iv 59 Cenomed 59 HCV Protease Inhibitor 59 sumatriptan succinate 59 Proxy Proposals 59 Ltd Therapeutic Competitors 59 TYZEKA 59 SAR# [002] 59 Pharmion Corporation 59 Thalomid ® 59 Xenazine ® 59 Tibotec Pharmaceuticals Ltd. 59 Lung Cancer Drug 59 Expanded Indication 59 Gets FDA Clearance 59 label Lipofen R 59 ZALBIN 58 Thrombin topical Recombinant 58 non nucleoside inhibitor 58 Ceragenix 58 Orapred ODT 58 Vicriviroc 58 OTCBB HXBM developer 58 Cross Licensing Agreement 58 NASDAQ RNAI 58 Archemix Corp. 58 Nippon Shinyaku 58 TRANSDUR Bupivacaine 58 Schizophrenia Drug 58 Nascobal 58 sanofi aventis EURONEXT SAN 58 NUEDEXTA ™ 58 Initiate Clinical Trial 58 Gentamicin Surgical Implant 58 Supply Agreement 58 AnGes MG Inc. 58 commercialize AzaSite 58 Merger Transaction 58 Achieves Primary Endpoint 58 Reacquires 58 pradefovir 58 EHT AGN 58 Completes Enrollment 58 Aldara ® 58 Nasdaq ABII 58 Initiate Phase III 58 Novel Antibiotic 58 PF # [002] 58 PRAECIS PHARMACEUTICALS INCORPORATED 58 Diamyd Medical Diamyd 58 Prodrug 58 commercialize becocalcidiol patented 58 AnGes MG 58 Nasdaq XTLB 58 TRANSDUR Sufentanil 58 RELISTOR ® 58 Nasdaq CLDX 58 Formal Agreement 58 Licence Agreement 58 ZEVALIN ® 58 oral salmon calcitonin 58 Ofatumumab 58 DOR BioPharma Announces 58 CRMD# 58 TRACON Pharmaceuticals 58 Locteron exclusively 58 IL# PE#QQR 58 Cellegesic 58 IAP inhibitors 58 DepoMed 58 Jingxin Pharma 58 Influenza Vaccine Production 58 Therapeutic Competitors companiesandmarkets.com adEgemonye 58 Granted Orphan Drug 58 CD# CEA 58 Vion Pharmaceuticals 58 Nasdaq EPCT 58 NeoVisc R 58 rasagiline tablets 58 Representation Agreement 58 Kinase Inhibitor 58 TLR9 agonists 58 PDUFA Date 58 BUPHENYL R 58 Preotact 58 Submits IND 58 Receives Complete Response 58 Sign Licensing Agreement 58 Crofelemer budesonide foam 58 copromotion 58 Pivotal Study 58 commercialize OncoGenex lead 58 Anika Therapeutics 58 DRRX 58 elotuzumab 58 Pivotal Phase III 58 BioSyent Pharma 58 fipamezole 58 AzaSite Xtra 58 tiapamil 58 acne impetigo 58 Teikoku Pharma USA 58 anti CD3 monoclonal 58 Ethypharm SA 58 XL# XL# 58 molecular imaging radiopharmaceutical 58 Systemic Delivery 58 Urokinase 58 Epoch Biosciences 58 Ono Pharmaceutical 58 markets HP Acthar 58 Release Capsules 58 Inspire Pharma 58 POTELLIGENT R 58 Aegera Therapeutics 58 Submits Response 58 Amends Agreement 58 AMEX PTN 58 Purchase Option Agreement 58 Crowflight Announces 58 Study Evaluating 58 Initiate Phase 58 Solasia 58 NYSE Amex Listing 58 Generic Version Of 58 Nasdaq MYRX 58 NitroMist TM 58 Eligard R 58 Fovea Pharmaceuticals 58 POSIDUR TM 58 Intravenous Human 58 FDA Approvable Letter 58 Cavit Sciences Inc. 58 NeoVisc ® 58 Inc. OTCBB ALRX 58 GTC recombinant form 58 Galderma Pharma 58 StaphVAX R 58 Therapeutic Vaccine 58 Option Agreements 58 Osiris retains 58 HepeX B 58 Partnering Agreements 58 Eligard ® 58 Merck Serono division 58 Announces License Agreement 58 Roche OTC RHHBY 58 pralatrexate injection folate analogue 58 ATL# [001] 58 Akorn Strides 58 Announcement acc 58 Lovaza TM 58 Tamibarotene 58 selective androgen receptor modulator 58 apaziquone 58 Pandemic Influenza Vaccine 58 Alligator Bioscience AB 58 Vegenics 58 OTC BB NNVC.OB 58 MERREM IV 58 Mylan Receives Approval 58 Antiangiogenic 58 TAFA# 58 Tibotec BVBA 57 Primus Pharmaceuticals 57 Ercole Biotech 57 Nanophase Announces 57 Medoxomil 57 PDL# 57 Glufosfamide 57 Vaccine Candidate 57 Xyntha 57 Nanobody 57 Xoma Ltd 57 UVIDEM 57 Zeneus 57 Sapacitabine 57 Agenerase 57 Fortical R 57 UMN Pharma 57 XL# XL# XL# XL# 57 RTP #i 57 Investigational Compound 57 NYSE Amex PTN 57 P#X# antagonist 57 Merrimack Pharmaceuticals 57 Targeted Chemotherapy 57 Vaccinex 57 Belinostat 57 EvaMist TM 57 compound KOS 57 Janssen Pharmaceutica NV 57 Clinical Trial Evaluating 57 Orphan Drug designations 57 recombinant thrombin 57 Psivida 57 BioOne Corporation 57 NASDAQ ENMD 57 Aloprim TM allopurinol sodium 57 ABILIFY R 57 Phase Ib study 57 PentaStaph 57 Panzem R NCD 57 Vaccine Adjuvants 57 Ucyclyd Pharma Inc. 57 Lixisenatide 57 NASDAQ BDSI 57 LibiGel ® 57 Prolongs Survival 57 Vitaros 57 Nasdaq VRTX today 57 Pennsaid ® 57 mitogen activated ERK kinase 57 DARA logo 57 commercialize CK # 57 Advancing Drugs 57 commercialize telaprevir 57 Medicure Announces 57 PharmaVitae Profile 57 Enters Into Definitive 57 BLP# Liposome Vaccine 57 Therapeutic Antibodies 57 Canadian drugmaker Aeterna 57 Sanochemia 57 Preclinical Data 57 Rectogesic 57 Pulmonary Arterial Hypertension 57 Phase IIa clinical trials 57 Sigma Tau Pharmaceuticals 57 granting Isotechnika 57 Stock Repurchase Plan 57 GeneraMedix Inc. 57 Fast Track designations 57 Frova ® 57 product platforms AZX# 57 Nascobal ® 57 Financing Transactions 57 commercialize Dimebon 57 Nabi HB R 57 Virulizin R 57 Prism Pharmaceuticals 57 Bremelanotide 57 volociximab 57 Catalyst Biosciences 57 QuantRx Biomedical Corporation 57 Tumor Targeting 57 Fentanyl TAIFUN R 57 Nasdaq VRTX 57 Announce Commencement 57 Sumatriptan Succinate 57 Rotarix R 57 dihydrochloride Tablets 57 Exherin 57 Small Molecule 57 Biologics Manufacturing 57 NASDAQ BJGP 57 adenosine injection 57 Thrombin 57 Femring ® 57 Archemix 57 Nasdaq IDEV 57 Zegerid OTC 57 Sign Definitive Merger 57 ® decitabine 57 Calixa 57 commercialized DURECT 57 NASDAQ CGEN announced 57 Ophthotech 57 TRANSDUR ® 57 Maxy G# 57 Transdermal Drug 57 Supplemental Biologics License Application 57 BXT # 57 Enters Option Agreement 57 Million Convertible Debt 57 Phase 2b Trial 57 drug pipeline TAFA# 57 AMEX RGN 57 Transition Therapeutics 57 Anidulafungin 57 Syntonix Pharmaceuticals 57 CysDisplay R 57 ITAX 57 Kyowa Hakko Kogyo 57 Somatuline R Depot 57 BioElectronics Corporation Announces 57 subsidiaries visit http:/www.apricusbio.com 57 BioGlue ® 57 commercializing Loramyc ® 57 Oxford BioTherapeutics 57 Fujisawa Healthcare Inc. 57 Patents Issued 57 Announce Merger Agreement 57 ESTRASORB ® 57 Phase IIa trials 57 BioTie 57 Vicor Technologies Announces 57 oral prodrug 57 AMEX DDD 57 Joint Venture Agreements 57 Kosan Biosciences Incorporated 57 FDA Orphan Drug 57 CombinatoRx Incorporated 57 Quark Biotech 57 Panzem R 57 RAPTIVA 57 TRISENOX ® 57 Polysilicon Supply Agreement 57 RAPTIVA r 57 Ustekinumab 57 A5 Laboratories Inc. 57 PDE4 inhibitor 57 Announce Collaboration Agreement 57 Kosan dependence 57 REMOXY R 57 Key Milestones 57 REBETOL combination therapy 57 Ceflatonin ® 57 Nasdaq IMGN 57 Keryx Biopharma 57 epoprostenol sodium 57 Definitive Agreements 57 MorphoSys AG FSE MOR 57 Tyzeka Sebivo 57 Zenyaku Kogyo 57 Orexo 57 commercialize Aganocide compounds 57 ELADUR 57 liver resection surgeries 57 Auxilium Pharma 57 Bicifadine 57 Begins Shipment 57 Pegloticase 57 Private Placement Offering 57 Testim R 57 Ipsen SA 57 Zingo TM 57 PhosLo 57 HuMax CD4 57 Licensing Deal 57 Dr. Arndt Schottelius 57 STERIS Corporation Announces 57 Submits Application 57 Dendritic Nanotechnologies Inc. 57 POSIDUR TM ELADUR TM 57 Rescula 57 OTCBB NVDL 57 NASDAQ SCMP 57 Glassia 57 PLAVIX ® 57 Recombinant Protein 57 Termination Agreement 56 Cytokinetics specified 56 candidate REP# 56 Lamictal ODT 56 Amended Agreement 56 Cloretazine ® 56 NASDAQ PHRM 56 LHRH antagonist 56 Taglich Brothers Initiates Coverage 56 HuCAL GOLD R 56 Mln Private Placement 56 Hybridon 56 Archexin 56 Patent Broadly Covering 56 REMOXY POSIDUR ELADUR 56 Mitsubishi Tanabe Pharma 56 euro adhoc Intercell AG 56 EGRIFTA TM 56 PrevOnco 56 OTCBB PYTO FWB ET6 56 Previously Announced Private Placement 56 MT#/MEDI-# 56 ThermoDox R 56 UltiMAb 56 outlicensing 56 Valera Pharmaceuticals 56 LUCASSIN 56 PREOS R 56 Inc. OTCBB VIVK 56 Ropren 56 Patent Infringement Litigation 56 LFB Biotechnologies 56 Pirespa 56 RHEI Pharmaceuticals 56 ularitide 56 Elesclomol 56 Receives Tentative FDA 56 DOVP 56 Cynapsus Therapeutics Inc. 56 Reports Preclinical Data 56 PRN FDA Approves 56 Kaketsuken 56 methylnaltrexone 56 Bupropion HCl ER 56 Isis Pharma 56 Metastatic Melanoma 56 Ambrilia Biopharma 56 Campath ® 56 Exploit collaboration 56 Schweitzer Mauduit Announces 56 Convertible Promissory Note 56 Patents Covering 56 Acquires Exclusive 56 ospemifene 56 Nasdaq PGNX 56 Xcytrin R 56 Senesco Technologies 56 AzaSite Plus 56 NASDAQ DRRX 56 telomerase therapeutic 56 LentiVector technology 56 Binding Agreement 56 Biological License Application 56 Celgene Thalomid 56 JV SpeBio 56 OvaRex ® MAb 56 THALOMID 56 CEFF financings subject 56 Adentri 56 Proquin XR 56 EpiCeram 56 Teijin Pharma 56 Progenitor Cell 56 OTCBB NPHC 56 CyDex Pharmaceuticals 56 Share Repurchase Plan 56 FDA Approvals 56 Exelixis logo 56 Enters Into Exclusive 56 Biotie 56 Factor VIIa 56 Anturol TM 56 Confirmatory Phase 56 Use Thereof 56 Binding Letter 56 Glatiramer Acetate 56 glucokinase activator 56 JOULFERON 56 Durect 56 InStorage REIT Announces 56 Wafer Supply 56 Antithrombin 56 novel histone deacetylase 56 Biomarin 56 Inc. NASDAQ CEGE 56 small molecule thrombopoietin 56 Inc. www.micromet inc.com 56 GSK '# 56 compound PMX # 56 Agensys subsidiary 56 Clevudine 56 Unit Dose Budesonide 56 Captisol 56 Teikoku Seiyaku 56 Collaborators Publish 56 Loramyc 56 Somaxon Pharmaceuticals 56 Presents Preclinical 56 adecatumumab MT# 56 tafluprost 56 novel peptides 56 ZEGERID Capsules 56 Anti Tumor Activity 56 Onalta 56 ARRY # 56 NASDAQ AKRX 56 Topline Results 56 FDA Okays 56 histone deacetylase HDAC inhibitor 56 Pennsaid R 56 LymphoStat B TM 56 Santen Pharmaceutical Co. 56 Benicar HCT 56 Pazopanib 56 GeneraMedix 56 Dalbavancin 56 L BLP# 56 MorphoSys proprietary 56 ZALBIN ™ 56 TRAIL receptor antibodies 56 Nabi HB ® 56 Nascobal R 56 Arzerra TM 56 Announces Definitive Agreements 56 atacicept 56 NeutroPhase TM 56 Interferon Alpha 56 REG1 Anticoagulation System 56 Ganite ® 56 investigational humanized monoclonal antibody 56 Raptiva R 56 Enhanze 56 Maribavir 56 Marketing Authorization 56 Non Brokered Financing 56 Octreotide 56 X Ceptor 56 Azur Pharma 56 Nicotine Vaccine 56 COLAZAL R 56 Cancer Vaccines 56 Somatuline Depot 56 GlaxoSmithKline plc GSK 56 MBMI Closes 56 Zemiva TM 56 Ore Pharmaceuticals 56 Pirfenidone 56 Mitsubishi Tanabe 56 Rottapharm Madaus 56 Assignment Agreement 56 HepaGam B 56 Preclinical Development 56 Aviptadil 56 ViroChem Pharma Inc. 56 Advancis Pharmaceutical Corporation 56 Angiox ® 56 SYN X 56 REMICADE infliximab 56 Methylnaltrexone 56 Scancell 56 Act PDUFA date 56 BYETTA ® 56 TSX SHQ 56 Receives Shareholder Approval 56 Combination Agreement 56 Ascend Therapeutics 56 OTCBB IGXT 56 Onco TCS 56 Ixabepilone 56 Develops Novel 56 Betaseron ® 56 Pivotal Phase 56 SCIB1 56 Ozarelix 56 Veregen TM 56 vapreotide acetate 56 Teijin Pharma Limited 56 FDA Clearance 56 CollaRx GENTAMICIN SURGICAL IMPLANT 56 Resubmission 56 Takeda Pharma 56 KAI Pharmaceuticals 56 SOLODYN R 56 anti CD# monoclonal 56 Extends Collaboration 56 Valortim TM 56 Nasdaq ICOS 56 oral nucleoside analogue 56 Through Glycoscience R 56 Fabre Kramer 56 Teikoku Seiyaku Co. 56 Stockholder Approval 56 Biologic License Application 56 Non Dilutive 56 DPX Survivac 56 NanoTab 56 balsalazide disodium Capsules 56 NMP# ® 56 Immunomedics Announces 56 DosePro TM 56 ASX PGL 56 Flutiform TM 56 NASDAQ ISIS 56 NASDAQ CRXL 56 Taro Receives 56 Nasdaq CADX 56 Signs Option Agreement 56 VANTAS 56 sublicensee 56 dutogliptin 56 Otsuka Pharmaceutical 56 Biovail Laboratories International 56 candidate custirsen 56 Completes Reverse Merger 56 OTCQX QRXPY 56 HELSINN 56 GlaxoSmithKline Biologicals SA 56 TSX PLB 56 Application MAA 56 MedGenesis 56 R bivalirudin 56 acetonide FA 56 EP #R 56 Mimpara R 56 testosterone buccal system 56 Clofarabine 56 ALZA Corporation 56 Vitamin D analogue 56 RenaZorb TM 56 Mutual Recognition Procedure 56 Oral Insulin 56 NOTE POSIDUR ™ 55 Zentaris 55 Strengthens Balance Sheet 55 Janssen AI 55 Molecular Diagnostic Test 55 RELISTOR 55 EMD Biosciences Inc. 55 Signs Binding Letter 55 Nasdaq ALNY 55 Nasdaq AUXL 55 RenaZorb 55 targeted radiotherapeutic 55 ForSight Newco II 55 Accelerated Approval 55 Ascent Therapeutics 55 proteasome inhibitor 55 Clavis Pharma 55 Closes Merger 55 Nasdaq PHRM 55 dextromethorphan quinidine 55 Amend Merger Agreement 55 RSD# iv 55 TYGACIL 55 Pivotal Clinical Trial 55 & LSE GLPG 55 VISICOL R 55 Portola Pharmaceuticals Inc. 55 Les Laboratoires Servier 55 HCV polymerase 55 Nitec 55 Completes Dosing 55 defensin mimetic antibiotic 55 License Agreements 55 SulphCo Announces 55 Integra LifeSciences Announces 55 Orphan Therapeutics 55 Genpharm 55 Cara Therapeutics 55 Exclusive Distribution 55 FY# Loss Widens 55 Shigamabs ® 55 Tissue Repair 55 Mundipharma 55 ONSOLIS 55 Prodarsan R 55 SansRosa 55 Valeant Pharma 55 immunosuppressive compound 55 INCB# [001] 55 Inhalation Aerosol 55 First Patient Enrolled 55 small molecule glucokinase 55 Entereg R 55 Preotact R 55 Flexpoint Announces 55 Announces Definitive Merger 55 TKM Ebola 55 * olmesartan medoxomil 55 Dealmaking Profile 55 Bionutrics 55 Evoltra ® 55 Obtains Exclusive License 55 Inc. Nasdaq IMGN 55 Roche SWX ROG 55 DOE USEC 55 Protexia ® 55 Terminate Merger Agreement 55 Franchise Agreements 55 Secures Financing 55 Stimuvax R 55 Ceflatonin R 55 WinRho R SDF 55 OTCBB APCSF 55 Kineret R 55 Lumacan 55 RhuDex ® 55 OTCBB PYTO 55 Submits Supplemental 55 Wafer polifeprosan 55 Demonstrates Sustained 55 OvaRex R 55 Trial Evaluating 55 EntreMed Inc. 55 Ganite 55 Besivance 55 Perifosine 55 Plicera 55 Loramyc R 55 Formal Option Agreement 55 Nasdaq OMER 55 STO SOBI 55 Eniluracil 55 NASDAQ LGND 55 Wellstat Therapeutics 55 TKPHF 55 SPL# Gel vaginal microbicide 55 Master License Agreement 55 tramiprosate ALZHEMED TM 55 albinterferon alfa 2b 55 AQM Copper Inc. 55 NASDAQ CRTX 55 BTG plc 55 FDA Clears 55 therapeutic monoclonal antibodies 55 Napo Pharmaceuticals 55 Romidepsin 55 RxKinetix 55 MAXY alpha 55 Restated Promissory Note 55 Announces Licensing Agreement 55 BRILINTA 55 Sankyo Co. 55 IgG1 monoclonal antibody 55 Akorn Inc 55 SUMAVEL 55 Drug Eluting Stent System 55 SURFAXIN 55 Announce Licensing Agreement 55 IAP inhibitor 55 Aflibercept 55 Gastrotech 55 Epitomics 55 Closes Financing 55 Testosterone MDTS ® 55 MKC# MKC# PP 55 Atripla combines 55 Lescarden 55 Biovitrum AB 55 A5 Laboratories 55 Roche SIX RO 55 Partnering Guide 55 Gestiva TM 55 Completes Financing 55 AndroGel R 55 PhosLo R 55 Emisphere Technologies 55 Enrolls First 55 PROLACRIA ™ 55 PLK1 SNALP 55 aerosolized AAT 55 Protexia R 55 Reseller Agreement 55 PDS PDS 55 Nasdaq CYCC Nasdaq CYCCP 55 product candidate Lpathomab 55 Safinamide 55 Begin Clinical Trials 55 Renvela ® 55 commercialize dutogliptin 55 DepoCyt 55 Proprius Pharmaceuticals 55 Progenics Pharmaceuticals